Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

Summary

The efficacy and safety of methylprednisolone in acute ischemic stroke patients with large infarct cores (ASPECTS score \< 6 or infarct volume ≥50 mL) due to anterior circulation large vessel occlusion have not been clearly established. This is a multi-center, randomized, double-blind, placebo-controlled trial to investigate early combination therapy with methylprednisolone for reperfusion in acute large core infarction.

Timeline

Start

2024-08-01

Primary completion

2025-09-30

Completion

2030-06-30

Drugs

Indications